Lyndra Therapeutics
Biotechnology ResearchUnited States51-200 Employees
As of March 26, 2025, Lyndra Therapeutics has ceased operations. Please direct any inquiries by email to Craig Jalbert at cjalbert@vlpc.com.
Insights
Recent Funding Milestone Lyndra Therapeutics secured a substantial $101 million in Series E funding recently, indicating strong investor confidence and potential for increased R&D activity or expansion in biopharmaceutical capabilities.
Strategic Partnerships The company's partnership with the National Institutes of Health and collaboration on opioid use disorder therapies present opportunities for government grants, joint ventures, and co-development projects with organizations focused on advancing healthcare solutions.
Ownership Transition Sun Pharmaceutical Industries' acquisition of a significant stake and eventual sale of Lyndra for $30 million suggests potential opportunities for acquisition integration, licensing agreements, or distribution collaborations within global markets.
Technological Focus Lyndra's innovative delivery technology for long-acting oral therapies positions it as a candidate for partnerships with pharmaceutical companies seeking advanced drug delivery solutions for chronic and underserved conditions.
Leadership and Talent Recent leadership changes and workforce adjustments highlight opportunities for talent acquisition, consulting services, or strategic alliances to support ongoing and future product development initiatives.
Similar companies to Lyndra Therapeutics
Lyndra Therapeutics Tech Stack
Lyndra Therapeutics uses 8 technology products and services including Open Graph, Underscore.js, SweetAlert, and more. Explore Lyndra Therapeutics's tech stack below.
- Open GraphContent Management System
- Underscore.jsJavascript Libraries
- SweetAlertJavascript Libraries
- jQuery MigrateJavascript Libraries
- SwiperJavascript Libraries
- YouTubeVideo Players
- Adobe Creative SuiteVisualisation Software
- IoniconsWeb Fonts
Media & News
Lyndra Therapeutics's Email Address Formats
Lyndra Therapeutics uses at least 1 format(s):
| Lyndra Therapeutics Email Formats | Percentage |
| FLast@lyndra.com | 50% |
| FLast@lyndra.com | 50% |
Frequently Asked Questions
Where is Lyndra Therapeutics's headquarters located?
Lyndra Therapeutics's main headquarters is located at 65 Grove St, Suite 301 Watertown, Massachusetts 02472, US. The company has employees across 1 continents, including North America. What is Lyndra Therapeutics's phone number?
You can contact Lyndra Therapeutics's main corporate office by phone at +1-817-415-****
What is Lyndra Therapeutics's official website and social media links?
Lyndra Therapeutics's official website is lyndra.com and has social profiles on LinkedInCrunchbase.What is Lyndra Therapeutics's SIC code NAICS code?
Lyndra Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Lyndra Therapeutics have currently?
As of October 2025, Lyndra Therapeutics has approximately 51 employees across 1 continents, including North America. Key team members include Vice President Clinical Development: P. B.Vice President Regulatory Affairs: M. C.President And Chief Executive Officer: A. J.. Explore Lyndra Therapeutics's employee directory with LeadIQ.What industry does Lyndra Therapeutics belong to?
Lyndra Therapeutics operates in the Biotechnology Research industry. What technology does Lyndra Therapeutics use?
Lyndra Therapeutics's tech stack includes Open GraphUnderscore.jsSweetAlertjQuery MigrateSwiperYouTubeAdobe Creative SuiteIonicons. What is Lyndra Therapeutics's email format?
Lyndra Therapeutics's email format typically follows the pattern of FLast@lyndra.com. Find more Lyndra Therapeutics email formats with LeadIQ. How much funding has Lyndra Therapeutics raised to date?
As of October 2025, Lyndra Therapeutics has raised $101M in funding. The last funding round occurred on Dec 21, 2023 for $101M.When was Lyndra Therapeutics founded?
Lyndra Therapeutics was founded in 2015.
Company Overview
- Headquarters
- 65 Grove St, Suite 301 Watertown, Massachusetts 02472, US
- Phone number
- +1-817-415-****
- Website
- lyndra.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2015
- Employees
- 51-200
Funding & Financials
- $101M
Lyndra Therapeutics has raised a total of $101M of funding over 7 rounds. Their latest funding round was raised on Dec 21, 2023 in the amount of $101M.
- $10M$25M
Lyndra Therapeutics's revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $101M
Lyndra Therapeutics has raised a total of $101M of funding over 7 rounds. Their latest funding round was raised on Dec 21, 2023 in the amount of $101M.
- $10M$25M
Lyndra Therapeutics's revenue is estimated to be in the range of $10M$25M
Company Leadership
P. B.Vice President Clinical Development
M. C.Vice President Regulatory Affairs- A. J.President And Chief Executive Officer
G. T.Co-Founder- T. B.Vp Of Financial Planning & Analysis
Employee Directory
- J. U.Vice President, Clinical Development
- M. C.Vice President Regulatory Affairs
- D. K.Senior Director, Workplace Operations And Safety
- T. S.Director
- C. Y. Z.Associate Director
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
